TOPIC

MEDICAL News & Analysis

Sale opens fertile ground for Healius
Stocks
Sale opens fertile ground for Healius
Offloading its medical centre and dental business will allow the healthcare company to pay down debt and focus on the turnaround of other units
Emma Rapaport | 18 June 2020
Avita’s share price burns will heal, says Morningstar
Stocks
Avita’s share price burns will heal, says Morningstar
The corona sell-off hurt the spray-on-skin maker but it’s got an eye on the bigger picture, says Nicolette Quinn
Emma Rapaport | 04 May 2020
Green shoots: Morningstar starts cannabis coverage
Stocks
Green shoots: Morningstar starts cannabis coverage
The legalisation of cannabis in Canada has boosted an industry that Morningstar forecasts will grow by nine times through 2030
Lex Hall | 19 July 2019
9 undervalued companies with 'exponential' growth potential: pt 3
Stocks
9 undervalued companies with 'exponential' growth potential: pt 3
3D Printing, Bioinformatics and Financial Services Innovation are set for exponential growth in coming years. In the final part of our series, we...
Lex Hall | 11 April 2019
9 undervalued companies with 'exponential' growth potential: pt 2
Stocks
9 undervalued companies with 'exponential' growth potential: pt 2
Energy & Environmental Systems; Medicine & Neuroscience; and Robotics: In part two of our series, we examine the changes taking place in...
Lex Hall | 04 April 2019
Ansell trades higher after guidance boost
Stocks
Ansell trades higher after guidance boost
Global industrial and medical glove maker Ansell is trading higher after raising its earnings guidance and posting a slight rise in first-half profit.
Lex Hall with AAP | 18 February 2019
US sales boost helps lift CSL H1 profit 6.8pc
Stocks
US sales boost helps lift CSL H1 profit 6.8pc
Pharmaceutical giant CSL has lifted first-half profit 6.8 per cent to $US1.16bn ($1.63bn), helped by increased drug sales in the US.
Lex Hall with AAP | 13 February 2019
Healius receives $2.02bn takeover offer
Stocks
Healius receives $2.02bn takeover offer
Australian hospital operator Healius has received a non-binding $2.02bn bid from a unit of its largest shareholder, China's Jangho Group, to buy it...
Lex Hall with AAP | 02 January 2019
Johnson & Johnson's fair value intact despite talc powder risks
Stocks
Johnson & Johnson's fair value intact despite talc powder risks
A pipeline of blockbuster products will help the household-name healthcare brand withstand a baby powder asbestos scare that has buffeted its share...
Lex Hall | 19 December 2018
Pharma stock looks attractive after latest acquisition
Stocks
Pharma stock looks attractive after latest acquisition
Australian Pharmaceutical Industries remains a buying opportunity following its $127 million acquisition of cosmetic skin and laser hair removal...
Emma Rapaport | 30 July 2018